Literature DB >> 3495305

The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia.

E Vellenga, D C Young, K Wagner, D Wiper, D Ostapovicz, J D Griffin.   

Abstract

A small subset of leukemic cells from most patients with acute myeloblastic leukemia (AML) have properties of stem cells and can be assayed by colony formation in agar or methylcellulose. Colony formation generally requires the addition of exogenous growth factors, but the exact factors required are incompletely defined. The AML colony-promoting activities of two recombinant human colony-stimulating factors (GM-CSF and G-CSF) were investigated by using blasts from 48 patients with AML. In nine cases, no colonies formed with either CSF. In seven cases colonies formed only in response to G-CSF and in 11 cases only in response to GM-CSF. In 21 cases colonies formed in response to either GM-CSF or G-CSF, and in 12 of these cases there was an additive effect between the two CSFs in determining maximum colony size. For cases responding to both GM- and G-CSF, the total number of colonies formed in response to the combination of both CSFs was almost always less than additive compared with the number of colonies formed in response to the individual CSFs. Further, the AML-CFU responding to either GM-CSF or G-CSF could not be distinguished by surface markers or by the cytochemical staining pattern of the colonies. These results suggest that there is considerable overlap between the GM-CSF- and G-CSF-responsive AML-CFU subpopulations in most cases. For five of seven cases, the combination of GM-CSF and G-CSF could replace a leukocyte feeder layer in providing maximum growth stimulation. These results indicate that GM-CSF and G-CSF are active growth factors for AML cells and are frequently additive in promoting maximum colony size.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495305

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

Review 1.  The role of colony-stimulating factors in acute leukemia.

Authors:  F Herrmann; E Vellenga
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

Review 2.  Haemopoietic growth factors.

Authors:  N J Ketley; A C Newland
Journal:  Postgrad Med J       Date:  1997-04       Impact factor: 2.401

3.  Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control.

Authors:  W Oster; N A Cicco; H Klein; T Hirano; T Kishimoto; A Lindemann; R H Mertelsmann; F Herrmann
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

4.  Effect of granulocyte colony-stimulating factor on chemotherapeutic activity of cytosine arabinoside in acute leukemic cell lines.

Authors:  K E Cha; S Y Yoon; K N Lee
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

5.  Recombinant human colony stimulating factor-granulocyte/macrophage and -granulocyte, but not macrophage induce the development of a respiratory burst in primary human myeloid leukemic cells in vitro.

Authors:  K Geissler; G Tricot; G Grimm; P Siostrzonek; H Broxmeyer
Journal:  Blut       Date:  1989-09

6.  Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMT.

Authors:  T Czerw; M Labopin; N-C Gorin; S Giebel; D Blaise; P-Y Dumas; R Foa; M Attal; N Schaap; M Michallet; C Bonmati; H Veelken; M Mohty
Journal:  Bone Marrow Transplant       Date:  2014-04-07       Impact factor: 5.483

7.  Karyotype and in vitro-response to GM-CSF. Analysis of bone marrow cultures in leukemia, myelodysplasia and aplastic anemia.

Authors:  D Haase; C Fonatsch
Journal:  Blut       Date:  1990-03

Review 8.  Use and toxicity of the colony-stimulating factors.

Authors:  J R Schriber; R S Negrin
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

9.  Clonogenic growth of acute non-lymphocytic leukemia cells in serum-free medium.

Authors:  P A Bernabei; V Santini; O Dal Pozzo; R Bezzini; V Gattei; R Saccardi; G Rombolà; P R Ferrini
Journal:  Experientia       Date:  1988-10-15

10.  High titer autoantibodies to GM-CSF in patients with AML, CML and MDS are associated with active disease.

Authors:  A Sergeeva; Y Ono; R Rios; J J Molldrem
Journal:  Leukemia       Date:  2008-01-24       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.